Immunoglobulin light chain amyloidosis diagnosis and treatment algorithm 2021

Abstract Immunoglobulin light chain amyloidosis (AL) commonly presents with nephrotic range proteinuria, heart failure with preserved ejection fraction, nondiabetic peripheral neuropathy, unexplained hepatomegaly or diarrhea, and should be considered in patients presenting with these symptoms. More...

Full description

Bibliographic Details
Published in:	Blood Cancer Journal
Main Authors:	M. Hasib Sidiqi, Morie A. Gertz
Format:	Article
Language:	English
Published:	Nature Publishing Group 2021-05-01
Online Access:	https://doi.org/10.1038/s41408-021-00483-7

Similar Items

Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantation
by: M. Hasib Sidiqi, et al.
Published: (2018-07-01)

Long-term risk of myelodysplasia in melphalan-treated patients with immunoglobulin light-chain amyloidosis
by: Morie A. Gertz, et al.
Published: (2008-09-01)

Immunoparesis status in immunoglobulin light chain amyloidosis at diagnosis affects response and survival by regimen type
by: Eli Muchtar, et al.
Published: (2016-09-01)

Chinese consensus on the diagnosis and treatment of immunoglobulin light-chain cardiac amyloidosis
by: Kaini Shen, et al.
Published: (2024-01-01)

Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation
by: M Hasib Sidiqi, et al.
Published: (2018-04-01)

Modeling immunoglobulin light chain amyloidosis in Caenorhabditis elegans
by: Margherita Romeo, et al.
Published: (2025-07-01)

Risk factors for venous thromboembolism in immunoglobulin light chain amyloidosis
by: Katherine M. Bever, et al.
Published: (2016-01-01)

IgM-Related Immunoglobulin Light Chain (AL) Amyloidosis
by: Shayna Sarosiek, et al.
Published: (2022-11-01)

Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis
by: Rajshekhar Chakraborty, et al.
Published: (2023-11-01)

Alterations of the gut microbiota in patients with immunoglobulin light chain amyloidosis
by: Jipeng Yan, et al.
Published: (2022-10-01)

Differences in immunoglobulin light chain species found in urinary exosomes in light chain amyloidosis (Al).
by: Marina Ramirez-Alvarado, et al.
Published: (2012-01-01)

The utility of splenic imaging parameters in cardiac magnetic resonance for the diagnosis of immunoglobulin light-chain amyloidosis
by: Niki Lama, et al.
Published: (2022-03-01)

A prospective study of nutritional status in immunoglobulin light chain amyloidosis
by: Prayman T. Sattianayagam, et al.
Published: (2013-01-01)

WCN24-2458 Renal response to treatment in patients with immunoglobulin light chain amyloidosis
by: Carlos Federico Varela, et al.
Published: (2024-04-01)

Systemic Immunoglobulin Light Chain Amyloidosis Presenting as Painful Penile Ulcers
by: Crystal Lihong Yan, et al.
Published: (2022-09-01)

Advances in the treatment of hereditary transthyretin amyloidosis: A review
by: Morie A. Gertz, et al.
Published: (2019-09-01)

Supportive Care and Symptom Management for Patients With Immunoglobulin Light Chain (AL) Amyloidosis
by: Christopher E. Jensen, et al.
Published: (2022-06-01)

Budd-Chiari syndrome as the presenting feature of systemic immunoglobulin light chain amyloidosis
by: João Luís Miranda, et al.
Published: (2025-03-01)

Restrictive Atrial Dysfunction in Cardiac Amyloidosis: Differences between Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patients
by: Mathijs O. Versteylen, et al.
Published: (2022-07-01)

Melphalan, lenalidomide and dexamethasone for the treatment of immunoglobulin light chain amyloidosis: results of a phase II trial
by: Vaishali Sanchorawala, et al.
Published: (2013-05-01)

Translocation t(11;14) and survival of patients with light chain (AL) amyloidosis
by: Alan H. Bryce, et al.
Published: (2009-03-01)

Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis.
by: Tanya L Poshusta, et al.
Published: (2009-01-01)

Case Report: A missed diagnosis of cardiac amyloidosis using echocardiography due to immunoglobulin light chain amyloidosis with normal wall thickness in the early stage
by: Xiaohui Li, et al.
Published: (2024-12-01)

Oxidative damage in immunoglobulin light chain and transthyretin cardiac amyloidosis – a closer look
by: Elena Cavallone, et al.
Published: (2024-05-01)

Update on treatment of light chain amyloidosis
by: Shameem Mahmood, et al.
Published: (2014-02-01)

The Clinical Characteristics of Immunoglobulin Light Chain Amyloidosis in the Chinese Population: A Systematic Scoping Review
by: Chengcheng Fu, et al.
Published: (2022-12-01)

LIGHT CHAIN AMYLOIDOSIS
by: Paolo Milani, et al.
Published: (2018-03-01)

Light chain (AL) amyloidosis: update on diagnosis and management
by: Rosenzweig Michael, et al.
Published: (2011-11-01)

Exploiting endogenous and therapy-induced apoptotic vulnerabilities in immunoglobulin light chain amyloidosis with BH3 mimetics
by: Cameron S. Fraser, et al.
Published: (2022-10-01)

Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis
by: Giovanni Palladini, et al.
Published: (2021-03-01)

Genome-wide association study of clinical parameters in immunoglobulin light chain amyloidosis in three patient cohorts
by: Iman Meziane, et al.
Published: (2017-10-01)

Updated recommendations for the treatment of light-chain amyloidosis from the Swiss Amyloidosis Network
by: Max J. Rieger, et al.
Published: (2025-07-01)

Prognostic factors in Chinese patients with immunoglobulin light chain amyloidosis: a scoping review and meta-analysis
by: Yu Wu, et al.
Published: (2024-12-01)

Amyloidogenic immunoglobulin light chains disturb contractile function and calcium transients in a human cardiac spheroid model of light chain (AL) amyloidosis
by: Mélanie Bézard, et al.
Published: (2025-02-01)

Pseudoxanthoma Elasticum and Light-Chain Amyloidosis
by: M. Carlesimo, et al.
Published: (2012-09-01)

Review and Progress in the Treatment of Renal Light Chain Amyloidosis
by: SHI Hao
Published: (2024-01-01)

Treatment patterns and outcomes in light chain amyloidosis: An institutional registry of amyloidosis report in Argentina.
by: Maria Lourdes Posadas-Martinez, et al.
Published: (2022-01-01)

Concurrent Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patient Treated With Daratumumab and Tafamidis: A Case Report
by: Taiki Nishihara, et al.
Published: (2025-08-01)

Evaluation of Cytokine Levels in Cardiac Transthyretin and Immunoglobulin Light Chain Amyloidosis and Their Correlation with Myocardial Inflammatory Cells and MACE
by: Nicolas Musigk, et al.
Published: (2025-09-01)

Revised renal stratification and progression models for predicting long-term renal outcomes in immunoglobulin light chain amyloidosis
by: Muhammad Umaid Rauf, et al.
Published: (2025-06-01)